Prospective evaluation of echocardiography and serum biomarkers as predictors of cardiotoxicity in patients with breast cancer treated with anthracyclines, taxanes, with/without trastuzumab

被引:3
|
作者
Solar Lopez, Jorge
De Las Penas, Ramon
De Avila, Leticia
De Julian, Maria
Amal, Maria
Martinez-De Duenas, Eduardo
Olmos, Santiago
Lopez-Rodriguez, Angela
Munarriz, Javier
Peset, Ana
Cortell, Alejandro
Rodriguez, Candela
Solloso, Angel
机构
[1] Oncol Serv Hosp Prov Castellon, Castellon de La Plana, Spain
[2] Hosp Prov, Castellon de La Plana, Spain
[3] Oncol Serv, Castellon de La Plana, Spain
[4] Hosp Prov Castellon, Castellon de La Plana, Spain
[5] Serv Cardiol, Castellon de La Plana, Spain
关键词
D O I
10.1200/jco.2014.32.15_suppl.e20686
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
e20686
引用
收藏
页数:1
相关论文
共 50 条
  • [41] Defining the metabolomic profile associated with early cardiotoxicity in patients with breast cancer treated with anthracyclines
    Cocco, D.
    Ferro, E. G.
    Ricci, S.
    Deidda, M.
    Noto, A.
    Madeddu, C.
    Atzori, F.
    Scarlozzi, M.
    Mercuro, G.
    Dessalvi, C. Cadeddu
    EUROPEAN HEART JOURNAL, 2020, 41 : 3289 - 3289
  • [42] A Prospective Cohort Study on Cardiotoxicity of Adjuvant Trastuzumab Therapy in Breast Cancer Patients
    Matos, Erika
    Jug, Borut
    Blagus, Rok
    Zakotnik, Branko
    ARQUIVOS BRASILEIROS DE CARDIOLOGIA, 2016, 107 (01) : 40 - 47
  • [43] Cardiotoxicity in HER2 positive breast cancer patients treated with trastuzumab
    Lopez, M.
    Minguito Carazo, C.
    Delgado Sillero, I.
    Rojas Piedra, M.
    Tavara Silva, B.
    Lopez-Gonzalez, A.
    Castanon Lopez, C.
    Nieto Mangudo, B.
    Pedraza Lorenzo, M.
    Rodriguez Sanchez, A.
    Diz Tain, P.
    De Sande Gonzalez, L. M.
    Medina Valdivieso, S.
    Lopez Gonzalez, L.
    Honrado Franco, E.
    Garcia-Palomo, A.
    Sanchez-Cousido, L. F.
    ANNALS OF ONCOLOGY, 2020, 31 : S332 - S332
  • [44] Association between pathologic complete response and survival in patients treated with sequential anthracyclines and concomitant taxanes and trastuzumab in HER2-positive breast cancer
    Mehta, R. S.
    Hsiang, D.
    Lane, K.
    Butler, J.
    CANCER RESEARCH, 2009, 69 (02) : 244S - 245S
  • [45] A prospective study of vinorelbine and capecitabine combination therapy in patients with metastatic breast cancer pretreated with anthracyclines and taxanes
    Xu, B.
    Fan, Y.
    Tian, L.
    Li, Q.
    EJC SUPPLEMENTS, 2009, 7 (02): : 283 - 283
  • [46] Prospective evaluation of liposomal doxorubicin (LD) in patients with metastatic breast cancer previously treated with conventional anthracyclines
    Bernardi, D.
    Errante, D.
    Stefani, M.
    Ramello, M.
    Bianco, A.
    Salvagno, L.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [47] Are statins preventive of cardiotoxicity in breast cancer patients treated with anthracyclines? A single center retrospective analysis
    Catia Oliveira, C.
    Santos, L.
    Pinho, A.
    Palma, P.
    Moreira, H.
    Rocha, M.
    Cabrita, A.
    Marques, C.
    Paiva, M.
    Sousa, C.
    Macedo, F.
    EUROPEAN JOURNAL OF HEART FAILURE, 2024, 26 : 574 - 575
  • [48] Cardiotoxicity manifestations in metastatic breast cancer patients treated with trastuzumab as first line.
    Sherman, Shira
    Barkan, Tamar
    Yerushalmi, Rinat
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [49] Usefulness of NT-ProBNP as a biomarker of cardiotoxicity in breast cancer patients treated with trastuzumab
    Blancas, I.
    Martin, C.
    Martin-Perez, F. J.
    Legeren, M.
    Martos, M.
    Sequero, S.
    Carnenero, S.
    Perez-Garcia, M. E.
    Rodriguez-Gonzalez, C. J.
    Jurado, J. M.
    Delgado, M.
    Gonzalez-Astorga, B.
    Gonzalez-Cebrian, I.
    Garrido, J. M.
    Prieto, C.
    Bayo-Martin, V.
    Fernandez-Gutierrez, M. I.
    Ayala-Carbonero, G.
    Reyes-Larzategui, S.
    Rodriguez-Serrano, F.
    ANNALS OF ONCOLOGY, 2019, 30 : 72 - +
  • [50] Time Trends of Left Ventricular Ejection Fraction and Myocardial Deformation Indices in a Cohort of Women with Breast Cancer Treated with Anthracyclines, Taxanes, and Trastuzumab
    Tan, Timothy C.
    Bouras, Souhila
    Sawaya, Heloisa
    Sebag, Igal A.
    Cohen, Victor
    Picard, Michael H.
    Passeri, Jonathan
    Kuter, Irene
    Scherrer-Crosbie, Marielle
    JOURNAL OF THE AMERICAN SOCIETY OF ECHOCARDIOGRAPHY, 2015, 28 (05) : 509 - 514